Human IMP Dehydrogenase 1/IMPDH1組換え体(リコンビナント)タンパク質 | Recombinant Human IMP Dehydrogenase 1/IMPDH1

R&D Systems社製の高品質なHuman IMP Dehydrogenase 1/IMPDH1の組換え体タンパク質(Recombinant Human IMP Dehydrogenase 1/IMPDH1)です。

※本製品は研究用です。研究用以外には使用できません。

※バルク包装品も承ります。お気軽にお問合せ下さい。

R&D Systems社組換え体タンパク質製品では通常ウシ血清アルブミン(BSA)をキャリアタンパク質として加えています。キャリアタンパク質を加えることで組換え体タンパク質の安定性が高まり、使用期限が長くなります。また、より濃度の低い溶液での保管も可能となります。CF製品はBSAが含まれない製品となります。一般的に細胞培養や、ELISAのスタンダードにはBSA含有製品を推奨しています。CF製品はBSAが影響してしまうアプリケーションに推奨されます。

IMPDH1 (inosine monophosphate dehydrogenase) is a ubiquitous cytosolic and nuclear enzyme that plays a central role in guanine nucleotide metabolism. It catalyzes the NAD-dependent conversion of inosine monophosphate (IMP) to hypoxanthine monophosphate (XMP) which is a precursor for the synthesis of GMP, guanosine, and guanine. These compounds are critical for DNA synthesis and cell proliferation (1, 2). IMPDH1 associates into a homotetramer of approximately 55 kDa subunits, and the tetramers can aggregate into perinuclear structures (3, 4). IMPDH1 binds to the nucleotides AMP, ATP, IMP, and XMP (4) as well as to single stranded DNA and RNA (5). It is inhibited by the immunosuppressant drug mycophenolic acid (MPA) (3, 6) which induces reversible IMPDH1 aggregation (7). It is required for vascular endothelial cell proliferation and the terminal differentiation of adipocytes (8, 9). Mutations of IMPDH1 are associated with autosomal dominant retinitis pigmentosa (4, 10). Human IMPDH1 shares 98% amino acid sequence identity with mouse and rat IMPDH1. Alternative splicing generates additional isoforms with internal deletions or variable substitutions at the N-terminus.